DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $615,000 | -51.7% | 30,485 | -10.7% | 0.03% | -50.0% |
Q2 2021 | $1,274,000 | +45.1% | 34,146 | -0.5% | 0.07% | +36.0% |
Q1 2021 | $878,000 | +21.9% | 34,319 | +5.0% | 0.05% | -3.8% |
Q4 2020 | $720,000 | -61.9% | 32,676 | -68.9% | 0.05% | -14.8% |
Q3 2020 | $1,889,000 | +13.5% | 104,990 | +60.3% | 0.06% | +41.9% |
Q2 2020 | $1,664,000 | +5.0% | 65,494 | -24.1% | 0.04% | +2.4% |
Q1 2020 | $1,585,000 | -55.2% | 86,289 | -46.2% | 0.04% | -16.0% |
Q4 2019 | $3,535,000 | +600.0% | 160,452 | +356.4% | 0.05% | +733.3% |
Q3 2019 | $505,000 | – | 35,155 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |